🇺🇸 Continued cotrimoxazole prophylaxis in United States

Continued cotrimoxazole prophylaxis (Continued cotrimoxazole prophylaxis) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Continued cotrimoxazole prophylaxis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Continued cotrimoxazole prophylaxis approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Continued cotrimoxazole prophylaxis in United States?

Medical Research Council is the originator. The local marketing authorisation holder may differ — check the official source linked above.